NCT01844505 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 316
- group Id
- BG001
- value
- 314
- group Id
- BG002
- value
- 315
- group Id
- BG003
- value
- 945
- units
- Participants
- groups
- description
- Nivolumab monotherapy 3 mg/kg intravenous (IV) once every 2 weeks (Q2W) until disease progression or unacceptable toxicity
- id
- BG000
- title
- Nivolumab
- description
- Nivolumab 1 mg/kg IV combined with Ipilimumab 3 mg/kg IV once every 3 weeks (Q3W) for 4 doses followed by nivolumab 3 mg/kg IV Q2W until disease progression or unacceptable toxicity
- id
- BG001
- title
- Nivolumab + Ipilimumab
- description
- Ipilimumab monotherapy 3 mg/kg IV Q3W for a total of 4 doses
- id
- BG002
- title
- Ipilimumab
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.92
- value
- 58.7
- group Id
- BG001
- spread
- 13.86
- value
- 59.3
- group Id
- BG002
- spread
- 13.23
- value
- 60.8
- group Id
- BG003
- spread
- 13.69
- value
- 59.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 108
- group Id
- BG002
- value
- 113
- group Id
- BG003
- value
- 335
- title
- Female
- measurements
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 206
- group Id
- BG002
- value
- 202
- group Id
- BG003
- value
- 610
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 308
- group Id
- BG001
- value
- 310
- group Id
- BG002
- value
- 303
- group Id
- BG003
- value
- 921
- title
- WHITE
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- BLACK OR AFRICAN AMERICAN
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 10
- title
- ASIAN
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- AMERICAN INDIAN OR ALASKA NATIVE
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 11
- title
- OTHER
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- NOT REPORTED
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- All randomized participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 316
- group Id
- BG001
- value
- 314
- group Id
- BG002
- value
- 315
- group Id
- BG003
- value
- 945
- units
- Participants
- groups
- description
- Nivolumab monotherapy 3 mg/kg intravenous (IV) once every 2 weeks (Q2W) until disease progression or unacceptable toxicity
- id
- BG000
- title
- Nivolumab
- description
- Nivolumab 1 mg/kg IV combined with Ipilimumab 3 mg/kg IV once every 3 weeks (Q3W) for 4 doses followed by nivolumab 3 mg/kg IV Q2W until disease progression or unacceptable toxicity
- id
- BG001
- title
- Nivolumab + Ipilimumab
- description
- Ipilimumab monotherapy 3 mg/kg IV Q3W for a total of 4 doses
- id
- BG002
- title
- Ipilimumab
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.92
- value
- 58.7
- group Id
- BG001
- spread
- 13.86
- value
- 59.3
- group Id
- BG002
- spread
- 13.23
- value
- 60.8
- group Id
- BG003
- spread
- 13.69
- value
- 59.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 108
- group Id
- BG002
- value
- 113
- group Id
- BG003
- value
- 335
- title
- Female
- measurements
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 206
- group Id
- BG002
- value
- 202
- group Id
- BG003
- value
- 610
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 308
- group Id
- BG001
- value
- 310
- group Id
- BG002
- value
- 303
- group Id
- BG003
- value
- 921
- title
- WHITE
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- BLACK OR AFRICAN AMERICAN
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 10
- title
- ASIAN
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- AMERICAN INDIAN OR ALASKA NATIVE
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 11
- title
- OTHER
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- NOT REPORTED
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- All randomized participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle